Abstract:Background: A better understanding of the molecular mechanisms that manifest in the immunosuppressive tumor microenvironment (TME) is crucial for developing more efficacious immunotherapies for hepatocellular carcinoma (HCC), which has a poor response to current immunotherapies. Regulatory T (Treg) cells are key mediators of HCC-associated immunosuppression. We investigated the selective mechanism exploited by HCC that lead to Treg cells expansion and to find more efficacious immunotherapies. Methods: We used matched tumor tissues and blood samples from 150 patients with HCC to identify key factors of Treg cells expansion. We used mass cytometry (CyTOF) and orthotopic cancer mouse models to analyze overall immunological changes after growth differentiation factor 15 (GDF15) gene ablation in HCC. We used flow cytometry, coimmunoprecipitation, RNA sequencing, mass spectrum, chromatin immunoprecipitation and Gdf15-/-, OT-I and GFP transgenic mice to demonstrate the effects of GDF15 on Treg cells and related molecular mechanism. We used hybridoma technology to generate monoclonal antibody to block GDF15 and evaluate its effects on HCC-associated immunosuppression. Results: GDF15 is positively associated with the elevation of Treg cell frequencies in patients wih HCC. Gene ablation of GDF15 in HCC can convert an immunosuppressive TME to an inflammatory state. GDF15 promotes the generation of peripherally derived inducible Treg (iTreg) cells and enhances the suppressive function of natural Treg (nTreg) cells by interacting with a previously unrecognized receptor CD48 on T cells and thus downregulates STUB1, an E3 ligase that mediates forkhead box P3 (FOXP3) protein degradation. GDF15 neutralizing antibody effectively eradicates HCC and augments the antitumor immunity in mouse. Conclusions: Our results reveal the generation and function enhancement of Treg cells induced by GDF15 is a new mechanism for HCC-related immunosuppression. CD48 is the first discovered receptor of GDF15 in the immune system which provide the possibility to solve the molecular mechanism of the immunomodulatory function of GDF15. The therapeutic GDF15 blockade achieves HCC clearance without obvious adverse events.

Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells

FGF21 suppresses CD8 + T cell antitumour activity

Cancer-associated adipocytes mediate CD8+T cell dysfunction via FGF21-driven lipolysis

FGF21 in obesity and cancer: New insights

Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice

FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K–Akt–mTOR signaling pathway

FBXO38 Mediates FGL1 Ubiquitination and Degradation to Enhance Cancer Immunity and Suppress Inflammation

FGF-21 Elevated IL-10 Production to Correct LPS-Induced Inflammation

Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21

Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment

FGF21 affects the glycolysis process via mTOR-HIF1α axis in hepatocellular carcinoma

Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling

FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1

Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat Cells

GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma

Fibroblast Growth Factor-21 Maintains Glucose Homeostasis Through Influencing the Expansion and Function of Subcutaneous Adipose Tissue

Ring Finger Protein 31–mediated Atypical Ubiquitination Stabilizes Forkhead Box P3 and Thereby Stimulates Regulatory T-cell Function

Silencing of FGF‐21 Expression Promotes Hepatic Gluconeogenesis and Glycogenolysis by Regulation of the STAT3–SOCS3 Signal

Fibroblast Growth Factor 21 Reverses Suppression of Adiponectin Expression Via Inhibiting Endoplasmic Reticulum Stress in Adipose Tissue of Obese Mice

Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.

Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors